December 17, 2019
Boston Scientific receives FDA clearance for single-use duodenoscope
Editor's Note
Boston Scientific announced December 13 that it had received Food & Drug Administration (FDA) 510(k) clearance for the EXALT Model D Single-Use Duodenoscope for use in endoscopic retrograde cholangiopancreatography (ERCP) procedures.
The EXALT Model D, which was granted Breakthrough Device Designation from the FDA, eliminates the need for duodenoscope reprocessing and repairs.
The company plans a limited market release of the duodenoscope in the US during the first quarter of 2020.
Free Daily News
- New guidance: Preoperative GLP-1s safe for surgical patients
- Study: Beta-blockers could increase postoperative stroke risk
- Music therapy reduces opioid use, anxiety in surgical patients
- Study: Poor sleep before surgery boosts risk of postoperative delirium
- GOP-controlled Senate to prioritize drug pricing, health agency reform
- Study links nurse burnout to lower patient safety, care quality
- Private Equity fuels growth of hospital-owned ASCs amidst rising demand, regulatory loopholes
- Outpatient facilities dominate healthcare construction as demand for community-based care grows
- OR Manager Conference session: Converting HOPDs to ASCs—What do hospitals need to know?
- AHA, FBI release resources to address targeted violence in healthcare
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement